Trial intelligence / Profile preview

Effect of dexmedetomidine on rocuronium pharmacokinetics in elective general surgery

ChiCTR-IPR-17012692Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Wenzhou Medical University
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine and rocuronium (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: rocuronium concentration, train-of-four ratio and 1 more. Planned start Oct 2017; status: not yet recruiting.

02

Drugs

dexmedetomidinerocuronium

Beyond the preview

Go deeper on ChiCTR-IPR-17012692.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17012692.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call